Sernova Corp (SEOVF)
0.235
-0.01
(-3.75%)
USD |
OTCM |
May 17, 16:00
Sernova Total Assets (Quarterly): 13.86M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 13.86M |
October 31, 2023 | 15.99M |
July 31, 2023 | 25.05M |
April 30, 2023 | 27.85M |
January 31, 2023 | 35.08M |
October 31, 2022 | 38.57M |
July 31, 2022 | 34.40M |
April 30, 2022 | 20.65M |
January 31, 2022 | 23.12M |
October 31, 2021 | 24.06M |
July 31, 2021 | 25.10M |
April 30, 2021 | 26.48M |
January 31, 2021 | 8.348M |
October 31, 2020 | 4.298M |
July 31, 2020 | 2.168M |
April 30, 2020 | 2.274M |
January 31, 2020 | 3.191M |
October 31, 2019 | 4.229M |
July 31, 2019 | 1.546M |
April 30, 2019 | 2.056M |
January 31, 2019 | 2.358M |
October 31, 2018 | 2.748M |
July 31, 2018 | 3.468M |
April 30, 2018 | 2.256M |
January 31, 2018 | 3.051M |
Date | Value |
---|---|
October 31, 2017 | 3.548M |
July 31, 2017 | 4.475M |
April 30, 2017 | 4.271M |
January 31, 2017 | 4.532M |
October 31, 2016 | 4.640M |
July 31, 2016 | 4.918M |
April 30, 2016 | 2.459M |
January 31, 2016 | 2.672M |
October 31, 2015 | 2.396M |
July 31, 2015 | 2.932M |
April 30, 2015 | 2.293M |
January 31, 2015 | 2.632M |
October 31, 2014 | 3.591M |
July 31, 2014 | 4.277M |
April 30, 2014 | 4.685M |
January 31, 2014 | 5.051M |
October 31, 2013 | 5.957M |
July 31, 2013 | 6.473M |
April 30, 2013 | 7.010M |
January 31, 2013 | 7.700M |
October 31, 2012 | 6.204M |
July 31, 2012 | 6.777M |
April 30, 2012 | 7.237M |
January 31, 2012 | 3.375M |
October 31, 2011 | 4.001M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.546M
Minimum
Jul 2019
38.57M
Maximum
Oct 2022
17.70M
Average
20.65M
Median
Apr 2022
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 11.00M |
Shareholders Equity (Quarterly) | 2.860M |